Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
1
|
pubmed:dateCreated |
1987-3-17
|
pubmed:abstractText |
Seventy-four patients treated for squamous cell carcinoma (SCC) of the nasopharynx were evaluated for the 5-year survival rate. The influence of stage, age, histological differentiation, total tumour dose and irradiation treatment technique (continuous vs. split-course) upon the survival was evaluated in 64 patients (palliations and histologically unclassified SCC were excluded). The 5-year survival rate in the whole group was 28/74 (38%), and in the group without palliations and unclassified SCC 26/64 (41%). The 5-year survival of patients with T1 carcinoma was better (8/9 = 89%) than of patients with T2 (4/14 = 29%), T3 (7/17 = 41%) and T4 (7/24 = 29%) carcinoma. In the group of 55 patients with T2, T3 and T4 carcinoma, those up to 50 years old had better survival (11/21 = 52%) than patients older than 50 years (7/34 = 21%) (p less than 0.01), patients treated with the tumour dose greater than 65 Gy had better survival (16/38 = 42%) than those treated with 50-65 Gy (2/17 = 12%) (p less than 0.05), and patients older than 50 years, with poorly differentiated carcinoma had better survival (7/20 = 35%) than those of the same age, with well-differentiated carcinoma (0/14 = 0%) (p less than 0.005). The split-course irradiation technique did not improved the 5-year survival rate, although on average the total tumour dose in this type of treatment was for 7.9 Gy higher than in the continuous irradiation.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:status |
MEDLINE
|
pubmed:month |
Jan
|
pubmed:issn |
0167-8140
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
8
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
25-32
|
pubmed:dateRevised |
2004-11-17
|
pubmed:meshHeading |
pubmed-meshheading:3809599-Adolescent,
pubmed-meshheading:3809599-Adult,
pubmed-meshheading:3809599-Age Factors,
pubmed-meshheading:3809599-Aged,
pubmed-meshheading:3809599-Aged, 80 and over,
pubmed-meshheading:3809599-Carcinoma,
pubmed-meshheading:3809599-Child,
pubmed-meshheading:3809599-Female,
pubmed-meshheading:3809599-Humans,
pubmed-meshheading:3809599-Male,
pubmed-meshheading:3809599-Middle Aged,
pubmed-meshheading:3809599-Nasopharyngeal Neoplasms,
pubmed-meshheading:3809599-Neoplasm Staging,
pubmed-meshheading:3809599-Prognosis,
pubmed-meshheading:3809599-Radiotherapy,
pubmed-meshheading:3809599-Radiotherapy Dosage,
pubmed-meshheading:3809599-Sex Factors
|
pubmed:year |
1987
|
pubmed:articleTitle |
Carcinoma of the nasopharynx: results of radiation treatment and some prognostic factors.
|
pubmed:publicationType |
Journal Article
|